Ayako Mizota, Kohei Shitara, Takayuki Fukui. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » Angiogenesis Inhibitors/therapeutic useAntibodies, Monoclonal/therapeutic useAntibodies, Monoclonal, HumanizedBevacizumabBrain Neoplasms/complicationsBrain Neoplasms/pathologyDyspnea/diagnosisDyspnea/etiologyFemaleHemangioendothelioma, Epithelioid/diagnosisHemangioendothelioma, Epithelioid/drug therapyHemangioendothelioma, Epithelioid/etiologyHumansLung Neoplasms/diagnosisLung Neoplasms/etiologyLymphatic MetastasisMiddle AgedTomography, X-Ray ComputedTreatment Outcome
Substances: See more » Angiogenesis InhibitorsAntibodies, MonoclonalAntibodies, Monoclonal, HumanizedBevacizumab
Year: 2011 PMID: 21317750 DOI: 10.1097/JTO.0b013e31820b9e23
Source DB: PubMed Journal: J Thorac Oncol ISSN: 1556-0864 Impact factor: 15.609